Sleep-Disordered Breathing in Ehlers-Danlos Syndrome: A Genetic Model of OSA

Objectives: The objective of this study was to investigate the presence of sleep-disordered breath- ing (SDB) in patients with Ehlers-Danlos syndrome. Ehlers-Danlos syndrome is a genetic disorder characterized by cartilaginous defects, including nasal-maxillary cartilages. Methods: A retrospective series of 34 patients with Ehlers-Danlos syndrome and complaints of fatigue and poor sleep were evaluated by clinical history, physical examination, polysomnography (PSG), and, in some cases, anterior rhinomanometry. Additionally, a prospective clinical investigation of nine patients with Ehlers-Danlos syndrome was performed in a specialized Ehlers-Danlos syndrome clinic. Results: All patients with Ehlers-Danlos syndrome evaluated had SDB on PSG. In addition to apneas and hypopneas, SDB included fl ow limitation. With increasing age, fl ow limitation decreased in favor of apnea and hypopnea events, but clinical complaints were similar independent of the type of PSG fi nding. In the subgroup of patients who underwent nasal rhinomanometry , increased nasal resistance was increased relative to normative values. Nasal CPAP improved symptoms. Patients with Ehlers-Danlos syndrome presenting to the medical clinic had symptoms and clinical signs of SDB, but they were never referred for evaluation of SDB. Conclusions: In patients with Ehlers-Danlos syndrome, abnormal breathing during sleep is com- monly unrecognized and is responsible for daytime fatigue and poor sleep. These patients are at particular risk for SDB because of genetically related cartilage defects that lead to the develop- ment of facial structures known to cause SDB. Ehlers-Danlos syndrome may be a genetic model for OSA because of abnormalities in oral-facial growth. Early recognition of SDB may allow treat- ment with orthodontics and myofacial reeducation.